The data from in vivo and in vitro studies reviewed above, regarding the IGF system components and their role in the development and progression of PCa, show a differential expression profile during the transformation of prostate epithelial cells from a benign to malignant or metastatic state. The gene discussed is IGF1; the disease is posterior cortical atrophy.